EUVIMEDEUVIMED entdecken
Open Access

NSUN2 Promotes Cancer Immune Evasion via Its Moonlighting Function Acting on Metabolic Reprogramming

Baoxiang Chen, Yanrong Deng, Xiang Zhai, Peiyun Wang, Kunming Lei, Siyuan Yin, Quanjiao Chen, Qun Qian, Jinfang Zhang, Xianghai Ren, Jianhong Zhao, Congqing Jiang

Cancer Communications · 01.01.2026 · 46

DOI: 10.34133/cancomm.0042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, online erschienen am 19.08.2026. Verfasst von Baoxiang Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P. R. China. Hauptthemen laut MEDLINE: Methyltransferases, Neoplasms, Tumor Escape. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although cancer immunotherapies have revolutionized cancer treatment, a substantial proportion of patients remain unresponsive. Elucidating the molecular mechanisms underlying tumor immune evasion and identifying key regulators are essential for improving immunotherapy efficacy. NOP2/Sun RNA methyltransferase 2 (NSUN2) exhibits widespread mutations across pan-cancer cohorts. This study aimed to delineate the noncanonical functions of NSUN2 in cancer immune modulation and explore its potential as a therapeutic target for cancer immunotherapy.

Methods

Multiple cancer cells expressing catalytically inactive NSUN2 mutants were generated and subjected to in vitro functional assays and in vivo studies in immunocompetent mouse models to evaluate their effects on tumor growth and antitumor immunity. Integrative multi-omics analyses, including transcriptomics, metabolomics, and mass spectrometry, were performed to elucidate the molecular mechanisms underlying NSUN2-mediated immune evasion. A proteolysis-targeting chimera (PROTAC) system was developed to achieve targeted degradation of NSUN2, and the clinical relevance of NSUN2 expression in predicting immunotherapy responses was assessed using institutional and public datasets.

Results

The enzymatically inactive NSUN2 mutant had minimal effects on tumor cell proliferation in vitro but markedly promoted tumor immune evasion in vivo. Multi-omics analyses revealed that NSUN2 induced metabolic reprogramming and elevated succinate levels, which suppressed cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling in tumor-associated macrophages (TAMs), thereby remodeling the tumor immune microenvironment and promoting M2-like TAM infiltration. Mechanistically, NSUN2 interacted with GATA-binding protein 3 (GATA3) through its methyltransferase domain, relieving GATA3-mediated transcriptional repression of succinate-CoA ligase GDP/ADP-forming subunit α and β genes (SUCLG1 and SUCLG2), leading to succinate accumulation. A newly developed NSUN2-targeting PROTAC demonstrated therapeutic efficacy and safety in combination with cancer immunotherapy. Clinically, low NSUN2 expression was associated with improved immunotherapy responses and survival.

Conclusions

Taken together, these findings revealed a noncanonical role of NSUN2 in reshaping the tumor immunosuppressive microenvironment, positioning NSUN2 as a pivotal repressor of cancer immunity and a promising immunotherapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesNeoplasmsTumor EscapeAnimalsHumansMetabolic ReprogrammingMiceImmunotherapyCell Line, TumorProteolysis Targeting ChimeraTumor MicroenvironmentMutation

Substanzen

MethyltransferasesProteolysis Targeting Chimera

Autor:innen und Institutionen

  • Hubei Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
  • Clinical Center of Intestinal and Colorectal Diseases of Hubei Province, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
  • Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
  • Low Rectal Cancer Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
  • Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC, Canada.
  • Department of Colorectal and Anal Surgery, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei, P. R. China.

Zitieren

APA

Chen, B., Deng, Y., Zhai, X., Wang, P., Lei, K., Yin, S., Chen, Q., Qian, Q., Zhang, J., Ren, X., Zhao, J., & Jiang, C. (2026). NSUN2 Promotes Cancer Immune Evasion via Its Moonlighting Function Acting on Metabolic Reprogramming. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0042

Vancouver

Chen B, Deng Y, Zhai X, Wang P, Lei K, Yin S, et al. NSUN2 Promotes Cancer Immune Evasion via Its Moonlighting Function Acting on Metabolic Reprogramming. Cancer Communications. 2026;46. doi:10.34133/cancomm.0042

BibTeX
@article{Chen2026,
  author = {Chen, Baoxiang and Deng, Yanrong and Zhai, Xiang and Wang, Peiyun and Lei, Kunming and Yin, Siyuan and Chen, Quanjiao and Qian, Qun and Zhang, Jinfang and Ren, Xianghai and Zhao, Jianhong and Jiang, Congqing},
  title = {NSUN2 Promotes Cancer Immune Evasion via Its Moonlighting Function Acting on Metabolic Reprogramming},
  journal = {Cancer Communications},
  year = {2026},
  volume = {46},
  doi = {10.34133/cancomm.0042}
}
Kostenlos starten →